That work belongs in a clinic
Reminder: Retatrutide remains investigational it is in Phase 3 trials (TRIUMPH program) and is not approved for human use as of 2026
When patients with hepatitis C were given standard therapy or standard therapy with a B12 injection of 5,000mcg, every 4 weeks for 48 weeks, those with the additional B12 responded better to treatment (18)
If these side effects or any other symptoms which you think are because of this medicine persist for a longer duration, please consult your doctor
Prescription orders will be held up to 3 business days awaiting approval from your vet
By correcting magnesium imbalances, BPC-157 may contribute to improved bone mineralization, muscle contraction, and overall musculoskeletal function